Zoloft in shortage due to increased demand during pandemic

The FDA added Zoloft, one of the most commonly prescribed antidepressants in the U.S., to its list of drugs in shortage as demand for the drug has spiked during the COVID-19 pandemic, Bloomberg reports. 

Advertisement

Zoloft is used to treat depression, obsessive-compulsive disorder and post-traumatic stress disorder. Demand for the drug rose 12 percent year over year in March, according to Bloomberg. The FDA added it to its shortage list May 29. 

Generic drugmakers told the FDA they weren’t able to get enough active pharmaceutical ingredients to make the drug. They told Bloomberg they expect the shortage to last for a couple of months. 

Read the full article here.

More articles on pharmacy:
American Pharmacists Association swears in new CEO
5 recent CMS pharmacy policy changes
Sanofi shakes up leadership, brings in 4 new execs

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.